MiniMed Delivers Strong Start to Fiscal Year 2027 with U.S. Growth Acceleration
NORTHRIDGE, Calif., Sept. 1, 2026 // -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today reported financial results for its first quarter (Q1) of fiscal year 2027 (FY27), ended July 31, 2026."MiniMed delivered an excellent start to our fiscal year, with accelerating U…
NORTHRIDGE, Calif., Sept.
1, 2026 // -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today reported financial results for its first quarter (Q1) of fiscal year 2027 (FY27), ended July 31, 2026."MiniMed delivered an excellent start to our fiscal year, with accelerating U…